- Report
- May 2025
- 185 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- April 2025
- 110 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- July 2024
- 144 Pages
Global
From €2239EUR$2,500USD£1,909GBP
- Report
- June 2025
- 173 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- May 2024
- 180 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- February 2024
- 110 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- March 2024
- 150 Pages
Global
From €2911EUR$3,250USD£2,481GBP
€4344EUR$4,850USD£3,703GBP
- Report
- December 2023
- 172 Pages
Global
€4474EUR$4,995USD£3,814GBP
- Report
- October 2024
- 100 Pages
Global
From €3500EUR$4,186USD£3,088GBP
The Arbovirus Testing market is a subset of the larger Infectious Disease Testing market. It is focused on the detection of arboviruses, which are a group of viruses transmitted by arthropods such as mosquitoes, ticks, and sandflies. These viruses can cause a range of illnesses, including dengue, chikungunya, Zika, and yellow fever. Arbovirus Testing is used to diagnose and monitor these diseases, as well as to track the spread of arboviruses in a given population.
Arbovirus Testing is typically performed using molecular techniques such as PCR and RT-PCR, as well as serological methods such as ELISA and immunofluorescence. These tests are available from a variety of companies, including Abbott, Bio-Rad, Cepheid, DiaSorin, Hologic, and Roche. Show Less Read more